Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/14/2003CN1418248A Altered strain of modified vaccinia virus ankara (MVA)
05/14/2003CN1418225A Monoclonal antibodies to the human ldl receptor, their production and use
05/14/2003CN1418224A TCF responsive element
05/14/2003CN1418223A Novel human hepatoma associated protein and coding sequence thereof
05/14/2003CN1418222A Novel peptide and screening method by using the same
05/14/2003CN1418105A Use of MIA in immunotherapy
05/14/2003CN1417574A Microelectronic detector on chip
05/14/2003CN1417340A Expression of human interleukin-12 in craze noctuid and its purifying process
05/14/2003CN1417339A High temperature-resisting cellulase gene sequence and its encoded polypeptide and prepn process
05/14/2003CN1417338A High temperature-resisting DNA polymerase gene sequence and its encoded polypeptide and prepn process
05/14/2003CN1417337A Dehydrating gene BcDh2 and the application of its promoter in raising drought tolerant plant
05/14/2003CN1417336A Application of orychophiagmus violaceus ODREB2B gene in raising drought tolerant plant
05/14/2003CN1417335A Dehydrating gene BcDh1 and application of its promoter in raising drought tolerant plant
05/14/2003CN1417334A Recombinant gene of soluble part in tumor necrosis factor acceptor and its fusion gene and product
05/14/2003CN1417333A Cloning, Expression and bioactivity of new actinion toxin
05/14/2003CN1417332A Recombinant gene of soluble part in cytolytic T cell relative antigen 4 and its fusion gene and product
05/14/2003CN1417331A Biological steel gene and its encoded protein
05/14/2003CN1417330A Meltiple antigenic compound Bt gene and its application in plant
05/14/2003CN1417329A Polyepitope malaria vaccine and its encoding gene
05/14/2003CN1417324A Guinea pig aeromonad as efficient chitin degrading bacterium and produced chitinase system
05/14/2003CN1417231A Prepn of recombinant human parathyroid hormone PTH (1-34)
05/14/2003CN1417229A Human tumor necrosin relative death inducing ligand mutein and its prepn process and medicine composition
05/14/2003CN1417223A CR1 gene related to cell reconstitution, conduction and death
05/14/2003CN1417222A Biological steel gene and its encoded protein
05/14/2003CN1417221A Biological steel gene and its encoded protein
05/14/2003CN1416899A Prepn of cancer-treating medicine
05/14/2003CN1416894A Secreted recombinant human interferon alpha-2a injection liquid
05/14/2003CN1416893A Medicine containing recombinant human metallothionein and its prepn
05/14/2003CN1108579C Method and apparatus for performing pattern dictionary formation for use in sequence homology detection
05/14/2003CN1108383C Deaminated formylase capable of increasing heat resistance and its prep.
05/14/2003CN1108382C Gene for fatty acid desaturase, vector containing said gene, plant cell containing said gene transferred thereinto
05/14/2003CN1108375C Method for continuous producing protein using recombined phage in membrane bioreactor
05/13/2003WO2004039826A1 Anti-il-6 antibodies, compositions, methods and uses
05/13/2003US6564151 Assigning protein functions by comparative genome analysis protein phylogenetic profiles
05/13/2003US6563026 Hybrid winter oilseed rape and methods for producing same
05/13/2003US6563025 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease, pest and herbicide resistant plants
05/13/2003US6563024 Process for transformation of mature trees of Eucalyptus plants
05/13/2003US6563023 Nucleotide sequences coding preferential polypeptide; for use as tool in genetic engineering
05/13/2003US6563022 Plant has an expression cassette containing a gene coding for an enzyme selected from endoxyloglucan transferase, catalase and peroxidase
05/13/2003US6563021 Production of cotton fiber with improved fiber characteristics
05/13/2003US6563020 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant crop plants
05/13/2003US6563019 Genetically engineering disease and stress resistant plants; obtain cells, incubate with vector contain iron binding protein, transform cells, recover transformed cells, express vector, monitor and evaluate cell activity
05/13/2003US6563018 Comprising sequence for GAL4 transcription activator and promoter sequence, wherein expression regulatory sequences are integrated in the P-element sequence in such manner that their downstreams are in opposite directions
05/13/2003US6563017 In vivo electroporation method for early stage embryo of chickens
05/13/2003US6563016 Perlecan transgenic animals and methods of identifying compounds for the treatment of amyloidoses
05/13/2003US6563015 Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) and mutant APP in brain and uses thereof
05/13/2003US6563014 Self-contained system for sustained viral replication
05/13/2003US6562960 Oligonucleotide analogues
05/13/2003US6562959 Detection of altered expression of genes regulating cell proliferation
05/13/2003US6562951 Method of solubilization and naturation of somatotropins
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562948 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562799 DNA binding proteins that are modified such that they are stable under non-hypoxic as well as hypoxic conditions
05/13/2003US6562798 Immunostimulatory oligonucleotides with modified bases and methods of use thereof
05/13/2003US6562784 Indications of mannan-binding lectin (MBL) in the treatment of immunocompromised individuals
05/13/2003US6562624 Methods and materials for the rapid and high volume production of a gene knock-out library in an organism
05/13/2003US6562623 Method for introducing a substance into a cell
05/13/2003US6562622 Continuous in vitro evolution
05/13/2003US6562619 Genration of preferential cell pools; prepare nutrient broth containing growth factor, inoculate with cells, propagate cells, recover cells
05/13/2003US6562618 Monoclonal antibody for use in the treatment of connective tissue, cancers, arteriosclerotic, skin and kidney disorders
05/13/2003US6562617 Library of fusion nucleic acids for use as diagnostic tools in genetic engineering
05/13/2003US6562613 Recombinant C-proteinase and processes, methods and uses thereof
05/13/2003US6562612 Cellulase producing actinomycetes, cellulase produced therefrom and method of producing same
05/13/2003US6562611 Composition containing heat resistant nuclease for use in the treatment of liver disease and cancer
05/13/2003US6562609 Oxidoreductase for use in human therapeutics and diagnostics
05/13/2003US6562607 Bacterial culture for use in generation of preerential enzymatic polypeptide and glutamic acid
05/13/2003US6562604 Transferring particles through cell barriers; insert cell into electrically conductive fluid, monitor electrical current, adjust voltage to maintain preferential diffusion
05/13/2003US6562599 Single-stranded antibody against hepatitis B virus core protein, gene thereof, and therapeutic agent for hepatitis B containing these
05/13/2003US6562598 Factor X deletion mutants and analogues thereof
05/13/2003US6562597 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
05/13/2003US6562596 Provides purified and isolated polypeptide products having primary structural conformation and biological properties of naturally occurring mammalian tissue inhibitor of metalloproteinase type three
05/13/2003US6562595 Nucleic acids; fungicides
05/13/2003US6562594 Generating preferential polypeptide by way of mutagenic exposure; obtain nucleotide sequences, incubate with mutagen, recover nucleotide sequences, incubate with primer and polymerase mixture, amplify, recover nucleotide sequences
05/13/2003US6562593 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/13/2003US6562592 Nucleotide sequencs coding membrane protein for use in the treatment and prevention of bone, cardiovascular, cancer or central nervous system disorders
05/13/2003US6562591 Cell cycle protein for use in the diagnosis and tratment of cancer and cell proliferative disorders
05/13/2003US6562589 AIB1, a novel steroid receptor co-activator
05/13/2003US6562588 Sialidase and recombinant cell lines
05/13/2003US6562587 Polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof
05/13/2003US6562584 Culture for use in the generation of 2-keto-L-gulonic acid
05/13/2003US6562580 Detection of preferential binding protein; obtain kinase protein, incubate with potential binding protein, monitor activity of kinase, adjustment in activity indicates bound protein
05/13/2003US6562576 Detecting preferential protein activity; obtain yeast cell, generate preferential protein in cell, detect reporter molecules
05/13/2003US6562570 Detection of binding site on nucleotide sequences; obtain nucleotide sequences, incubate with nuclease, transferases and random sequences, hybridize primers, propagate sequences, determine nucleotide sequences
05/13/2003US6562568 Isolation of preferential nucleotide sequences from sample; obtain cell sample, lyse, expose to suspension of magnetic glass particles in isopropanol, removing non-bound sample components, elute and separate eluate from glass particles
05/13/2003US6562566 Determination sequence of preferential nucleic acids; provide hybridization matrix, exposing nucleotide sequences fragment to hybridization matrix, determine positions of hybridization deduce sequence of nucleic acid
05/13/2003US6562565 Determining copy number of preferential nucleotide sequences; generate solid support, conjugate with target sequences, incubate with nucleotide sequence samples, detect binding, compare to control
05/13/2003US6562564 Decreasing cell proliferation by decreasing levels of PP5
05/13/2003US6562563 Detection of modulator of mitochondrial permeability transition; obtain cell containing mitochondrion, incubate with modulator, exposing cell to excitation energy, detect energy transfer, compare to control
05/13/2003US6562349 Otitis media vaccine
05/13/2003US6562348 Recombinant M. tuberculosis auxotrophic for leucine and vaccines using same
05/13/2003US6562346 Fusion protein consisting of NS3, NS4 and NS5a polypeptides of hepatitus C virus with epitopes selected from sequence number 1 and/or 2
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6562341 Antibodies specific for native PrPSc
05/13/2003US6562340 A cellulase with a xylanase, protease, amylase, glucoamylase, lipase, pectinase, mannanase, galactosidase, arabinofurosidase and/or phytase; increasing digestibility
05/13/2003US6562333 Purified mammalian CTLA-8 antigens and related reagents
05/13/2003CA2467719A1 Anti-il-6 antibodies, compositions, methods and uses
05/13/2003CA2227864C Dna strands coding for glycerol-3-phosphate acyltransferase
05/13/2003CA2105998C Human pf4a receptors and their use
05/13/2003CA2105979C Monoclonal antibody against lps core